Blood test study of immune cell markers in ICU sepsis
Part of Infections clinical trials.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated in the ICU for sepsis (a serious body-wide infection)
- You currently have a breathing tube (endotracheal tube) in place
- For comparison, you may be scheduled for an elective surgery with a planned blood draw or an IV placed
- If you are having planned surgery, you will also have an endotracheal tube for the procedure
- You cannot be on long-term immune-suppressing medicines (like chronic steroid pills) or have a known immune deficiency, transplant, or cancer-related immune suppression
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
This study looks at how your immune cells respond during a severe infection in the ICU. It aims to better predict how the infection will progress and help tailor treatment.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This study is testing two different simple blood tests to see which one better predicts sepsis (a severe infection response) and outcomes in ICU patients after surgery or trauma. It aims to help doctors identify high-risk patients sooner and improve care.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.